Uploaded September 2026 | Updated November 2026, 4 days ago
Multiple myeloma is the second-most common blood cancer, and while it is not considered curable, advances in treatment may offer better prognoses.
A Mayo Clinic hematologist and oncologist explains how new therapies and ongoing research are changing the outlook for people with the disease.
____________________________________________
FOR THE PUBLIC: More health and medical news on the Mayo Clinic News Network. newsnetwork.mayoclinic.org
FOR THE MEDIA ONLY: To access clean and NAT sound versions of this video on the Mayo Clinic News Network, register at newsnetwork.mayoclinic.org/request-account
Mayo Clinic: mayocl.in/3tNMAdF
Like Mayo Clinic on Facebook: facebook.com/MayoClinic
Follow Mayo Clinic on Instagram instagram.com/mayoclinic
Follow Mayo Clinic on X, formerly Twitter: https://x.com/MayoClinic
Follow Mayo Clinic on Threads: threads.net/@mayoclinic
Multiple myeloma is the second-most common blood cancer, and while it is not considered curable, advances in treatment may offer better prognoses.
A Mayo Clinic hematologist and oncologist explains how new therapies and ongoing research are changing the outlook for people with the disease.
____________________________________________
FOR THE PUBLIC: More health and medical news on the Mayo Clinic News Network. newsnetwork.mayoclinic.org
FOR THE MEDIA ONLY: To access clean and NAT sound versions of this video on the Mayo Clinic News Network, register at newsnetwork.mayoclinic.org/request-account
Mayo Clinic: mayocl.in/3tNMAdF
Like Mayo Clinic on Facebook: facebook.com/MayoClinic
Follow Mayo Clinic on Instagram instagram.com/mayoclinic
Follow Mayo Clinic on X, formerly Twitter: https://x.com/MayoClinic
Follow Mayo Clinic on Threads: threads.net/@mayoclinic










